Cannabinoids

Australia TGA Updates Six-Monthly Reporting Form for SAS and Authorised Prescriber Sponsors

In May 2026, the Australian Therapeutic Goods Administration updated its six‑monthly reporting form and guidance for sponsors of unapproved therapeutic goods supplied under the Special Access Scheme and Authorised Prescriber schemes. Sponsors of MDMA and psilocybine, medicinal cannabis and therapeutic vaping products must now ensure they use the updated template and email half‑yearly supply reports within one month of each reporting period, making timely data collection and compliance controls essential.

23 May 2026, 19:39tga.gov.auAustralia

Austria Issues RASFF Alert Over High THC and CBD in Fruit Gummies From Slovenia

In May 2026, Austrian authorities issued a serious EU RASFF alert after detecting very high levels of delta-9-THC and cannabidiol in fruit gummies from Slovenia and ordered market withdrawal and a public warning. This underscores strict enforcement of EU rules on unauthorised cannabis-derived ingredients in confectionery, signalling heightened recall and reputational risk for food operators marketing THC- or CBD-containing products across the single market.

23 May 2026, 09:09webgate.ec.europa.euEuropean UnionAustriaGermanySlovenia

Louisiana SB510 Sent to Governor to Prohibit Enticing Minors Onto Premises Selling Consumable Hemp Products

Louisiana has enrolled SB510 and sent it to the Governor; the bill would extend existing minors-on-premises alcohol rules to licensed venues where consumable hemp products are the principal commodities, with a stated effective date of 1 August 2026 if enacted. Businesses in Louisiana that sell consumable hemp products alongside alcohol should anticipate stricter age-access controls on their premises and review permits, layouts, and staff procedures in light of this likely change.

22 May 2026, 18:55legis.la.govUnited States

Delaware Hemp Regulation Act (HB 401) Fails To Gain Committee Release Signatures

In May 2026, Delaware’s proposed Hemp Regulation Act (HB 401), which would create a comprehensive licensing, testing, labelling, age-restriction, and taxation regime for hemp-derived cannabinoid products, failed to secure the signatures needed for release from its House committee. This setback lowers the immediate likelihood of enactment but signals that stringent regulation of hemp-derived products, including 21+ age limits, mandatory potency testing, child-safe labelling, and a 6% excise tax, remains a live policy direction that could re-emerge in future sessions.

21 May 2026, 08:54legis.delaware.govUnited States

China NMPA Incorporates Test Methods for Cannabidiol and Other Ingredients Into Cosmetics Safety Technical Specification (2015 Edition)

China’s National Medical Products Administration has issued Announcement No. 1 of 2026 to incorporate five supplementary test methods, including for cannabidiol in cosmetics, into the national Safety and Technical Standards for Cosmetics (2015 Edition). This strengthens regulatory oversight of cannabis-derived and other cosmetic raw materials in China by clarifying the official test methods that laboratories and manufacturers must follow for compliance assessments.

20 May 2026, 10:03nmpa.gov.cnChina

New Jersey Assembly Passes A5051 on Hemp, Intoxicating Hemp Beverages, and Medical Cannabis

In May 2026, the New Jersey Assembly passed Bill A5051 to tighten controls on hemp-derived cannabinoids, intoxicating hemp beverages, and aspects of medical cannabis licensing, and sent it to the Senate Judiciary Committee. If enacted, the measure would impose stricter THC content and packaging standards, extend temporary allowances to November 2026, and lock in new permissions for some dispensaries, forcing beverage, cannabis, and retail operators in New Jersey to reassess products, distribution, and compliance timelines.

20 May 2026, 08:30pub.njleg.govUnited States

Minnesota Senate Passes Omnibus Cannabis Bill Tightening Licensing, THC Limits, and Labelling

The Minnesota Senate has narrowly passed SF 4401, a far‑reaching omnibus cannabis bill that would overhaul licensing (including a new macrobusiness tier) and tighten THC potency, packaging, and labelling rules for both adult‑use cannabis and lower‑potency hemp edibles, but the measure still awaits House action and is not yet law. If enacted, cannabis and hemp businesses in Minnesota would face stricter serving‑size and THC limits, expanded health warnings and packaging requirements, and new endorsement‑based licence structures, requiring early planning to adjust product formulations, labelling, and licensing strategies ahead of staged effective dates.

15 May 2026, 18:35revisor.mn.govUnited States

New Jersey Assembly Advances Bill A5051 On Hemp, Intoxicating Hemp Beverages, And Medical Cannabis

New Jersey Assembly committees have advanced Bill A5051 (Aca, 1R), a detailed package revising state rules for hemp producers, intoxicating hemp beverages, and medical/adult-use cannabis licensing, moving it to second reading in May 2026. If enacted, the bill would extend key THC-related transition dates, tighten packaging, testing and sales-channel controls for intoxicating hemp beverages, and ease co-location and licensing of medical and adult-use dispensaries, requiring affected businesses to plan for potential operational changes by late 2026.

15 May 2026, 17:43njleg.state.nj.usUnited States

Vermont House Refers Bill S.323 on Agricultural, Pesticide, Seed, and Hemp Reforms to Appropriations Committee

Vermont’s omnibus agriculture bill S.323, which would tighten pesticide licensing, impose new registration and reporting duties for treated and genetically engineered seed, shift hemp and cannabinoid oversight to the Cannabis Control Board, and adjust farm, water and energy-siting rules, has been referred from the House floor to the Appropriations Committee following Senate passage and initial House review, with a proposed effective date of 1 July 2026. If enacted broadly as passed by the Senate, the bill would create new compliance burdens for pesticide dealers and applicators, seed distributors, hemp and cannabinoid businesses, and larger farm and energy projects in Vermont, so affected operators should track the remaining House process closely and begin planning for system, labelling and reporting changes.

15 May 2026, 09:40legislature.vermont.govUnited States

US DEA Finalises Schedule I Placement Of CUMYL-PEGACLONE (SGT-151)

In May 2026, the US Drug Enforcement Administration issued a final rule permanently placing the synthetic cannabinoid CUMYL-PEGACLONE (SGT-151) in Schedule I of the Controlled Substances Act, effective immediately. This cements the substance as a highly controlled drug, requiring full Schedule I registration and controls for any research or handling and effectively closing off legitimate commercial use in the US market while reinforcing US obligations under international drug control treaties.

14 May 2026, 18:52federalregister.govUnited States

Vermont S.323 Moves to House Ways and Means, Proposing Pesticide, Seed, and Hemp Regulatory Changes

In May 2026, Vermont’s omnibus agriculture bill S.323, which bundles significant changes to pesticide applicator licensing, seed labelling and reporting, hemp regulation, and farm permitting, passed the Senate and advanced to the House Ways and Means Committee. If enacted with its current text from July 2026, these reforms would tighten data and oversight requirements for pesticide-treated and genetically engineered seeds, bring many hemp-derived cannabinoids under stricter cannabis-style controls, and reshape compliance duties and costs for farms, agri‑businesses, and energy developers operating in Vermont.

10 May 2026, 19:19legislature.vermont.govUnited States

South Carolina Bill H.5667 Would Create Apothecary Retailer Licences for Hemp-Derived Cannabinoid and Wellness Products

South Carolina has introduced Bill H.5667 (Apothecary Retailer Act) to create a new apothecary retailer licence category and impose age, THC-content and marketing controls on hemp-derived cannabinoid, smoking-cession and wellness products sold in specialist outlets. If enacted, this would establish a distinct retail channel outside alcohol law, requiring manufacturers and retailers of cannabinoid and wellness products to align product formulations, labelling, and distribution strategies with South Carolina-specific THC limits and age-verification rules.

9 May 2026, 07:05scstatehouse.govUnited States

Connecticut HB 5350 (Public Act 26-8) Overhauls Cannabis, Hemp and Infused Beverage Regulation

Connecticut has advanced HB 5350 (now recorded as Public Act 26-8) to the final legislative stage, enacting wide-ranging statutory changes to cannabis, hemp, and infused beverage regulation that largely take effect from October 2026. These amendments reset THC and testing rules, expand permissible product types, tighten retailers’ data and credit practices, and create new licensing and tracking for hemp-derived extracts, requiring cannabis and beverage businesses to update formulations, lab arrangements, packaging, and compliance systems ahead of the effective date.

8 May 2026, 19:00cga.ct.govUnited States

Delaware HB 373 Moves To House Appropriations Committee On THC-Infused Beverages

In early May 2026, Delaware advanced HB 373, a bill to create a regulatory and tax framework for THC-infused beverages and to reclassify certain cannabinoids, by moving it from the Economic Development committee to the House Appropriations Committee. If ultimately enacted, the measure would impose new manufacturing, testing, record-keeping, packaging, age-restriction and excise tax obligations on THC beverage and cannabis businesses in Delaware, so affected companies should monitor the bill’s appropriations review and prepare for a possible 90-day post-enactment implementation window.

8 May 2026, 07:47legis.delaware.govUnited States

Delaware Legislature Introduces Delaware Hemp Regulation Act for Hemp-Derived Cannabinoid Products (HB 401)

Delaware has introduced HB 401 to establish the Delaware Hemp Regulation Act, creating a comprehensive licensing, testing, labelling, and taxation framework for retail sales of hemp-derived cannabinoid products to adults 21 and over. If enacted, this would significantly tighten controls on hemp-derived cannabinoids in Delaware, requiring new testing and packaging compliance, age-gated retail operations, and readiness for a 6% excise tax within a year of enactment or final regulations.

8 May 2026, 06:56legis.delaware.govUnited States

Delaware HB 395 Would Tighten Regulation of Intoxicating THC Consumable Products

Delaware House Bill 395 would amend state hemp and marijuana laws to bring intoxicating THC consumable products under the licensed adult-use marijuana regulatory framework. If enacted, retailers would need to channel higher-THC consumables through licensed outlets and meet stricter testing, labelling, packaging and age-restriction rules, reducing unregulated sales and exposure to minors.

5 May 2026, 07:23legis.delaware.govUnited States

EU Parliament Receives Draft Commission Regulations on Pesticide MRLs and Food Contaminants

European Commission draft regulations to amend pesticide maximum residue levels and food contaminant limits have been forwarded to the European Parliament’s ENVI committee under the regulatory procedure with scrutiny, with objection deadlines in June 2026. If they proceed, revised limits for specified pesticides, process contaminants and delta-9-THC in hemp food products will apply across the EU, requiring food and agriculture businesses to confirm future product and sourcing compliance.

5 May 2026, 06:52europarl.europa.euEuropean Union

EESC Opinion on Proposal to Amend Regulation (EU) No 1308/2013 (School Scheme, Protein Crops, Hemp and Marketing Standards)

In January 2026 the European Economic and Social Committee issued an opinion on the CMO reform proposal COM(2025)553, covering EU school food schemes, a new protein crops sector, hemp production rules, marketing standards and agri-food crisis preparedness. If taken up by the co-legislators, its recommendations would support risk-based regulation of hemp (including THC/CBD feed uses), stronger origin labelling and protected meat designations, and clearer timelines for transitioning EU school schemes and agri-food crisis mechanisms, reshaping planning for agricultural, food and hemp supply chains.

3 May 2026, 07:30eur-lex.europa.euEuropean Union

EU SCCS Issues Scientific Advice on Safe Use Levels of Cannabidiol (CBD) and THC in Cosmetic Products

In April 2026, the EU Scientific Committee on Consumer Safety issued final scientific advice setting safe use levels for CBD and trace THC in cosmetic products. These quantitative limits will now anchor EU safety assessments for CBD cosmetics, so brands using higher concentrations or hemp-derived materials must reassess formulations, impurity controls, and aggregate exposure across dermal and oral products.

29 Apr 2026, 06:51health.ec.europa.euEuropean Union

Norway Publishes Joint Guidance on CBD Rules Across Product Categories

Norway’s food and medicines regulators have issued joint guidance confirming that cannabis-derived CBD extracts remain classified as narcotics and that CBD is still banned in foods, drinks and supplements, with only tightly controlled uses in medicines and certain cosmetics using synthetic CBD. This consolidates existing EU and national rules and signals continued strict enforcement, so businesses selling CBD products in Norway need to reassess product portfolios, labelling and supply chains to avoid illegal offerings and potential seizures or sanctions.

28 Apr 2026, 11:57mattilsynet.noNorway